ArticleFrontiers in oncology2025
Deep learning-based survival analysis of bladder cancer patients in the Putuo District, Shanghai, China.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bladder cancer poses significant health risks and necessitates effective public health management. Objective: To develop a deep-learning survival prediction model using TabNet and compare its performance with logistic regression. Methods: Data on bladder cancer patients were collected from the Putuo District subset of Shanghai Cancer Registration and Reporting System. A total of 620 patients were included, divided into a training cohort (n=434) and a validation cohort (n=186). Logistic regression analyses were conducted to identify risk factors, while the TabNet framework was used to develop a deep learning-based model. Model performance was evaluated using ROC curves, decision curve analysis, and calibration curves. Shapley Additive Explanations (SHAP) was applied to interpret feature importance. Results: Baseline characteristics showed no significant differences between the training and validation cohorts (P>0.05). The TabNet model demonstrated high discriminative ability in predicting both 5-year OS and CSS within the training cohort, with net benefits surpassing those of logistic regression, and showed good calibration. In the validation cohort, the TabNet model exhibited excellent performance in predicting 5-year OS and CSS. SHAP analysis revealed that age, T stage, and N stage were the most influential factors. Conclusion: The TabNet model showed robust performance in predicting bladder cancer survival, offering valuable insights for community-based management and follow-up strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.